Subsequent investigations have revealed that IGF2BP3 upregulates USP49 expression through m6A modification, thereby enhancing SIRT1 stability and underscoring the critical role of m6A modification in RB resistance [245]. This evidence concerns the gene USP49 and retinoblastoma.